Gary Sender

Gary L.
Sender currently serves as Independent Director at Schrödinger, Inc. since 2019, Independent Director at iBio, Inc. since 2020, Director at Elucida Oncology, Inc. since 2021, Independent Director at Harmony Biosciences Holdings, Inc. since 2020, Director at Harmony Biosciences LLC, Director at Gennao Bio, Inc. since 2021, Director at Apnimed, Inc., and President at Sender Consulting LLC.
Former roles include Senior Vice President-Finance at Shire Plc from 2009 to 2015, CFO and Vice President-Finance & Administration at Tengion, Inc. from 2004 to 2009, Chief Financial Officer at Nabriva Therapeutics GmbH from 2016 to 2017, Chief Financial Officer & Executive Vice President at Synergy Pharmaceuticals LLC from 2015 to 2016, Chief Financial Officer at Nabriva Therapeutics Plc from 2016 to 2021, and Head-Investor Relations & Treasury at Merck & Co. Education includes an MBA from Carnegie Mellon University and undergraduate studies at Boston University.